Kaptchuk Ted J, Stason William B, Davis Roger B, Legedza Anna R T, Schnyer Rosa N, Kerr Catherine E, Stone David A, Nam Bong Hyun, Kirsch Irving, Goldman Rose H
Osher Institute, Harvard Medical School, Boston, MA, 02215 USA.
BMJ. 2006 Feb 18;332(7538):391-7. doi: 10.1136/bmj.38726.603310.55. Epub 2006 Feb 1.
To investigate whether a sham device (a validated sham acupuncture needle) has a greater placebo effect than an inert pill in patients with persistent arm pain.
A single blind randomised controlled trial created from the two week placebo run-in periods for two nested trials that compared acupuncture and amitriptyline with their respective placebo controls. Comparison of participants who remained on placebo continued beyond the run-in period to the end of the study.
Academic medical centre.
270 adults with arm pain due to repetitive use that had lasted at least three months despite treatment and who scored > or =3 on a 10 point pain scale.
Acupuncture with sham device twice a week for six weeks or placebo pill once a day for eight weeks.
Arm pain measured on a 10 point pain scale. Secondary outcomes were symptoms measured by the Levine symptom severity scale, function measured by Pransky's upper extremity function scale, and grip strength.
Pain decreased during the two week placebo run-in period in both the sham device and placebo pill groups, but changes were not different between the groups (-0.14, 95% confidence interval -0.52 to 0.25, P = 0.49). Changes in severity scores for arm symptoms and grip strength were similar between groups, but arm function improved more in the placebo pill group (2.0, 0.06 to 3.92, P = 0.04). Longitudinal regression analyses that followed participants throughout the treatment period showed significantly greater downward slopes per week on the 10 point arm pain scale in the sham device group than in the placebo pill group (-0.33 (-0.40 to -0.26) v -0.15 (-0.21 to -0.09), P = 0.0001) and on the symptom severity scale (-0.07 (-0.09 to -0.05) v -0.05 (-0.06 to -0.03), P = 0.02). Differences were not significant, however, on the function scale or for grip strength. Reported adverse effects were different in the two groups.
The sham device had greater effects than the placebo pill on self reported pain and severity of symptoms over the entire course of treatment but not during the two week placebo run in. Placebo effects seem to be malleable and depend on the behaviours embedded in medical rituals.
研究在持续性手臂疼痛患者中,一种假装置(一种经验证有效的假针灸针)是否比惰性药丸具有更大的安慰剂效应。
一项单盲随机对照试验,该试验源自两项嵌套试验的两周安慰剂导入期,这两项试验将针灸和阿米替林与其各自的安慰剂对照进行比较。继续使用安慰剂的参与者在导入期之后持续到研究结束。
学术医疗中心。
270名因重复性使用导致手臂疼痛的成年人,尽管接受了治疗,但疼痛至少持续了三个月,并且在10分制疼痛量表上的得分≥3分。
使用假装置进行针灸,每周两次,共六周;或服用安慰剂药丸,每天一次,共八周。
用10分制疼痛量表测量手臂疼痛。次要结局指标包括用莱文症状严重程度量表测量的症状、用普兰斯基上肢功能量表测量的功能以及握力。
在两周的安慰剂导入期内,假装置组和安慰剂药丸组的疼痛均有所减轻,但两组之间的变化无差异(-0.14,95%置信区间为-0.52至0.25,P = 0.49)。两组之间手臂症状严重程度评分和握力的变化相似,但安慰剂药丸组的手臂功能改善更为明显(2.0,0.06至3.92,P = 0.04)。在整个治疗期间对参与者进行跟踪的纵向回归分析显示,假装置组在10分制手臂疼痛量表上每周的下降斜率显著大于安慰剂药丸组(-0.33(-0.40至-0.26)对-0.15(-0.21至-0.09),P = 0.0001)以及在症状严重程度量表上(-0.07(-0.09至-0.05)对-0.05(-0.06至-0.03),P = 0.02)。然而,在功能量表或握力方面,差异不显著。两组报告的不良反应有所不同。
在整个治疗过程中,假装置在自我报告的疼痛和症状严重程度方面比安慰剂药丸具有更大影响,但在两周的安慰剂导入期内并非如此。安慰剂效应似乎具有可塑性,并且取决于医学仪式中所包含的行为。